Literature DB >> 2147957

4-[(Carboxymethyl)oxy]- and 4-[(carboxymethyl)amino]-5,7-dichloroquinoline-2-carboxylic acid: new antagonists of the strychnine-insensitive glycine binding site on the N-methyl-D-aspartate receptor complex.

B L Harrison1, B M Baron, D M Cousino, I A McDonald.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2147957     DOI： 10.1021/jm00174a005

Source DB:  PubMed          Journal:  J Med Chem        ISSN： 0022-2623            Impact factor:   7.446


× No keyword cloud information.
  4 in total

Review 1.  Neurodegeneration in Multiple Sclerosis: Symptoms of Silent Progression, Biomarkers and Neuroprotective Therapy-Kynurenines Are Important Players.

Authors:  Dániel Sandi; Zsanett Fricska-Nagy; Krisztina Bencsik; László Vécsei
Journal:  Molecules       Date:  2021-06-05       Impact factor: 4.411

Review 2.  KYNA Derivatives with Modified Skeleton; Hydroxyquinolines with Potential Neuroprotective Effect.

Authors:  Bálint Lőrinczi; István Szatmári
Journal:  Int J Mol Sci       Date:  2021-11-03       Impact factor: 5.923

3.  Synthetic- and DFT modelling studies on regioselective modified Mannich reactions of hydroxy-KYNA derivatives.

Authors:  Bálint Lőrinczi; Antal Csámpai; Ferenc Fülöp; István Szatmári
Journal:  RSC Adv       Date:  2020-12-24       Impact factor: 3.361

4.  Synthesis of Indole-Coupled KYNA Derivatives via C-N Bond Cleavage of Mannich Bases.

Authors:  Bálint Lőrinczi; Péter Simon; István Szatmári
Journal:  Int J Mol Sci       Date:  2022-06-28       Impact factor: 6.208
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.